By Megan Stride ( December 10, 2012, 4:41 PM EST) -- The Second Circuit preserved another Eli Lilly & Co. win Monday in a suit in multidistrict litigation alleging it failed to warn about diabetes risks tied to its antipsychotic Zyprexa, finding the two-year time limit on bringing such claims under Virginia law had run out....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.